These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3001182)

  • 21. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
    Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR
    Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between the expression of herpes simplex virus type 1 (HSV-1) glycoprotein C and both the maintenance of persistence in vitro and the capacity to establish latency in vivo.
    Mannini-Palenzona A; Bartoletti AM; Mannini F; Cassai E; Tognon M
    Microbiologica; 1988 Apr; 11(2):101-10. PubMed ID: 2841558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of murine and human nectin1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin1 to gD and a gD-dependent pathway of entry.
    Menotti L; Avitabile E; Dubreuil P; Lopez M; Campadelli-Fiume G
    Virology; 2001 Apr; 282(2):256-66. PubMed ID: 11289808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency.
    Dunkel EC; Green MT; Rosborough JP
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):525-33. PubMed ID: 6325365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
    Taylor JL; Casey MS; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping regions of herpes simplex virus type 1 glycoprotein I required for formation of the viral Fc receptor for monomeric IgG.
    Basu S; Dubin G; Nagashunmugam T; Basu M; Goldstein LT; Wang L; Weeks B; Friedman HM
    J Immunol; 1997 Jan; 158(1):209-15. PubMed ID: 8977192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of herpes simplex virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients with viral meningoencephalitis using primers for the glycoprotein D gene.
    Kúdelová M; Murányiová M; Kúdela O; Rajcáni J; Lehtinen M; Stankovic J; Arvaja M; Bálint O
    Acta Virol; 1995 Feb; 39(1):11-7. PubMed ID: 7572464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-herpes simplex virus effect of an aqueous extract of propolis.
    Huleihel M; Isanu V
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):923-7. PubMed ID: 12455181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable target-sensitive immunoliposomes.
    Pinnaduwage P; Huang L
    Biochemistry; 1992 Mar; 31(11):2850-5. PubMed ID: 1372514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an aciclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice.
    Johnson TP; Frey R; Modugno M; Brennan TP; Margulies BJ
    Int J Antimicrob Agents; 2007 Nov; 30(5):428-35. PubMed ID: 17851051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T lymphocytes activated by interleukin 2 alone acquire permissiveness for replication of herpes simplex virus.
    Braun RW; Kirchner H
    Eur J Immunol; 1986 Jun; 16(6):709-11. PubMed ID: 3013641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus.
    Ho RJ; Ting-Beall HP; Rouse BT; Huang L
    Biochemistry; 1988 Jan; 27(1):500-6. PubMed ID: 2831962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus.
    Lathey JL; Rouse BT; Wiley DE; Courtney RJ
    Immunology; 1986 Jan; 57(1):29-35. PubMed ID: 3002969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamics of the formation of antibodies to surface and internal proteins of the herpes simplex virus in a model experiment on rabbits].
    Zvonarev AIu; Cheliapov NV; Ebralidze LK; Malytseva NN
    Biull Eksp Biol Med; 1987 Oct; 104(10):476-8. PubMed ID: 2823927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties.
    McTaggart SP; Burns WH; White DO; Jackson DC
    J Immunol; 1978 Aug; 121(2):726-30. PubMed ID: 681755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.